The big picture: what is driving physician practice M&A?
The role of private investment, what doctors need to know, and what it all means for patients Levin Associates spoke with Dana Jacoby, the CEO and founder of Vector Medical Group, and Gary Herschman, a partner at Epstein Becker & Green, P.C., at the 6th annual Physician Transactions Conference in Las Vegas in March 2023. Their separate interviews have been combined into one Q&A, which has been lightly edited for clarity and brevity. What is the future of private equity and other outside investment in healthcare? Jacoby: I’m very bullish on the future of healthcare and I’m very excited about it. There’s just this crescendo of change coming into... Read More »
Takeaways from the 6th Annual Physician Transactions Conference
The role of private equity in healthcare was the focus of the 6th Annual Physician Transactions Conference on March 9, 2023. Physicians, private equity investors, investment bankers and other healthcare business leaders gathered in Las Vegas to talk about what independent practices need to know about brokering a deal with a private equity firm. Attendees posed questions to other physicians who have already entered into PE deals, and panelists provided insights to help physicians consider whether partnering with outside investors will be the right path forward for their practices. Levin Associates was in attendance at the conference. Here is a summary of the main... Read More »
Devices to Digital: Insights into the Medical Devices and eHealth Markets in Q1:23
The Medical Devices Market: As of May 26, 2023, a total of 46 Medical Device deals have been announced this year, and 28 of those deals were announced during Q1:23. The Q1:23 deal total is comparable to the 27 deals announced during Q1:22, yet an 18% drop from the 56 deals announced between January 1, 2022, and May 26, 2022. M&A activity is also 25% down compared to the 35 Medical Device deals announced during Q1:21, and 6% lower than the 49 deals announced between January 1, 2021, and May 26, 2021. While M&A is down compared to recent Q1’s, considering we just had a few years of unprecedented upheaval, the market is still at a better place than it was before the COVID-19 pandemic.... Read More »
Mixed Q1 2023 Results in the Diagnostics Sector: COVID-19 Testing Revenues Slump
The Diagnostics Market: Despite a bustling M&A market in 2022, the diagnostics sector appears to have experienced a slowdown in deal activity, though it still remains relatively strong compared with previous years. As of May 15, 2023, a total of 26 deals have been announced year-to-date. Although this represents a 42% decline compared to the 45 deals observed during the same period in 2022, it still signifies a substantial 44% and 86% increase from the deal count in 2021 and 2020, respectively. These figures highlight the enduring interest in the diagnostics market, which increased out of necessity during the COVID-19 pandemic and continues to drive investment and strategic... Read More »
April 2023 Healthcare M&A Market Update
According to recent data captured in the LevinPro HC database, the healthcare M&A market in April 2023 saw a total of 185 deals, an increase from the 169 deals in March 2023, yet a slight decrease from the 189 deals we saw in April 2022. The busiest sector in April 2023 was Physician Medical Groups (PMG), with 47 deals, followed by Other Services with 41 deals and eHealth with 24 deals. Private equity firms and their portfolio companies were responsible for acquiring 70 of the targets in April, making up 38% of all the deals announced during the month. One sector that saw a significant rise in deal totals was Medical Devices, with 12 deals announced in April 2023, compared to only... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
